CELSION
Celsion is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2. The company’s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications. Celsion also has two feasibility stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies.
CELSION
Industry:
Biotechnology Health Care Therapeutics
Founded:
1982-01-01
Address:
Lawrenceville, New Jersey, United States
Country:
United States
Website Url:
http://www.celsion.com
Total Employee:
11+
Status:
Active
Contact:
609-896-9100
Email Addresses:
[email protected]
Total Funding:
78.79 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-06-10 | EGEN | EGEN acquired by Celsion | N/A |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Celsion
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-19 | Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer |
Official Site Inspections
http://www.celsion.com Semrush global rank: 3.67 M Semrush visits lastest month: 3.84 K
- Host name: 208.209.208.35.bc.googleusercontent.com
- IP address: 35.208.209.208
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Celsion"
Celsion - Org Chart, Teams, Culture & Jobs | The Org
View Celsion's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Celsion Corporation Announces Company Name Change to …
LAWRENCEVILLE, N.J., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, today announced a company name …See details»
Imunon - Crunchbase Company Profile & Funding
Imunon is developing new medicines that harness the building blocks of life to work in harmony with the body’s immune system.See details»
Celsion Corporation - LinkedIn
Celsion Corporation is a fully integrated oncology company with a high-potential portfolio of innovative cancer treatments. With platform technologies in chemotherapy and gene-mediated ...See details»
Celsion Corporation Announces Company Name Change to
Sep 19, 2022 New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines LAWRENCEVILLE, N.J., Sept. 19, 2022 …See details»
Celsion Corporation Employee Directory, Headcount & Staff
Sep 17, 2024 Celsion Corporation Employee Directory Biotechnology Research United States 11-50 Employees Celsion Corporation is a fully integrated oncology company with a high …See details»
Celsion Corporation | VentureRadar
Celsion is a fully-integrated oncology company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA …See details»
Celsion Corporation Reports 2020 Financial Results and Provides ...
Dec 31, 2020 LAWRENCEVILLE, N.J., March 19, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company focused on DNA …See details»
Governance Celsion Corporation Nasdaq - MarketScreener.com
Nov 7, 2024 Find the composition of the Board of Directors of Celsion Corporation (Nasdaq Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»
CELSION CORPORATION ANNOUNCES CLOSING OF $15 MILLION …
Lawrenceville, NJ, April 05, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced the closing of its previously announced …See details»
Celsion - Overview, News & Similar companies | ZoomInfo.com
View Celsion (www.celsion.com) location in New Jersey, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Celsion Corporation Appoints Dr. Stacy R. Lindborg to its Board of ...
Jun 8, 2021 Dr. Lindborg brings to Celsion more than 25 years of pharmaceutical industry experience with a particular focus on R&D, executive management and strategy. She has …See details»
Celsion Corporation Establishes Wholly Owned Subsidiary to …
Celsion GmbH will manage current and future cancer studies with ThermoDox® Celsion continues its strategic focus on the development of GEN-1 and PLACCINE …See details»
Celsion Corporation Reports Third Quarter 2020 Financial Results …
Sep 30, 2020 Mr. Tardugno added, “As promised, Celsion has engaged a global biometrics contract research organization (CRO), with forensic statistical analysis capability that …See details»
Celsion Corporation - VentureRadar
"Celsion is a fully-integrated oncology company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA …See details»
NEW REPORT on Celsion Corporation - LinkedIn
Dec 9, 2020 Celsion Corporation (“Celsion” or “the Company”) is a fully integrated biopharmaceutical company focused on developing cancer therapies for difficult-to-treat forms …See details»
Celsion Corporation Reports 2019 Financial Results and Provides ...
Dec 31, 2019 LAWRENCEVILLE, N.J., March 25, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced …See details»
Celsion Corporation Reports 2021 Financial Results and Provides ...
LAWRENCEVILLE, N.J., March 31, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug-development company focused on DNA-based …See details»
Celsion Corporation Reports Second Quarter 2022 Financial …
Jun 30, 2022 About Celsion Corporation Celsion is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including …See details»
Celsion Corporation Reports Second Quarter 2021 Financial …
LAWRENCEVILLE, N.J., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug-development company focused on DNA-based immunotherapy …See details»